αίολος - dofaq.co
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
Reuters - 15 Feb 2024
GSK completes acquisition of Aiolos Bio for up to $1.4 bln ...
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace - 09 Jan 2024
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline ...
GSK, moving fast to buy Aiolos, pays $1B to challenge Amgen, AstraZeneca for asthma market
Fierce Biotech - 09 Jan 2024
GSK, moving fast to buy Aiolos, pays $1B to challenge Amgen, AstraZeneca for asthma market ...
Aiolos team, VCs steer asthma start-up into quick $1B sale to GSK
BioCentury - 10 Jan 2024
Aiolos team, VCs steer asthma start-up into quick $1B sale to GSK ...
GSK Expands Respiratory Portfolio with $1.4 Billion Acquisition of Aiolos Bio
The Healthcare Technology Report. - 19 Jan 2024
GSK Expands Respiratory Portfolio with $1.4 Billion Acquisition of Aiolos Bio ...
Aiolos Bio Launches With $245M As Asthma-Focused Funding Accelerates
Crunchbase News - 24 Oct 2023
Aiolos Bio Launches With $245M As Asthma-Focused Funding Accelerates ...
GSK acquires Aiolos Bio for $1.4bn to boost respiratory portfolio
Pharmaceutical Technology - 10 Jan 2024
GSK acquires Aiolos Bio for $1.4bn to boost respiratory portfolio ...
Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP ...
Business Wire - 24 Oct 2023
Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP ... ...
Aiolos Bio Expands Leadership Team With Key Hires
Contract Pharma - 12 Dec 2023
Aiolos Bio Expands Leadership Team With Key Hires ...
GSK Enters Agreement to Acquire Aiolos Bio
Yahoo Finance - 09 Jan 2024
GSK Enters Agreement to Acquire Aiolos Bio ...
Startup launches with $245 million for twice yearly asthma treatment
STAT - 24 Oct 2023
Startup launches with $245 million for twice yearly asthma treatment ...
GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn
Financial Times - 09 Jan 2024
GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn ...
JPM 2024: GSK Buys Aiolos Bio for $1.4 Billion, Cytokinetics Acquisition Sparks Three-way Contest
geneonline - 10 Jan 2024
JPM 2024: GSK Buys Aiolos Bio for $1.4 Billion, Cytokinetics Acquisition Sparks Three-way Contest ...
TSLP approach draws GSK to Aiolos buyout: $1B up front
BioWorld Online - 09 Jan 2024
TSLP approach draws GSK to Aiolos buyout: $1B up front ...
GSK Buys Aiolos Bio for Up to $1.4 Bln
MarketWatch - 09 Jan 2024
GSK Buys Aiolos Bio for Up to $1.4 Bln ...
JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos
pharmaphorum - 09 Jan 2024
JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos ...
Aiolos launches with $245m Series A to advance asthma therapies
Pharmaceutical Technology - 25 Oct 2023
Aiolos launches with $245m Series A to advance asthma therapies ...
GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug
STAT - 09 Jan 2024
GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug ...
Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments
Business Wire - 12 Dec 2023
Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments ...